Group One Trading’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Group One Trading’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-900	Closed	-$671	–	8569
2024 Q4	$671	Sell	900 -2,557	-74%	-$2.55K	﹤0.01%	6961
2024 Q3	$4.22K	Hold	3,457	–	–	﹤0.01%	5941
2024 Q2	$7.16K	Sell	3,457 -1,600	-32%	-$3.77K	﹤0.01%	5792
2024 Q1	$18.5K	Buy	5,057 +3,657	+261%	+$14K	﹤0.01%	5480
2023 Q4	$4.21K	Sell	1,400 -1,263	-47%	-$2.56K	﹤0.01%	6574
2023 Q3	$5.72K	Buy	+2,663	New	+$10.6K	﹤0.01%	6629
2023 Q2	–	Sell	-2,000	Closed	-$15.6K	–	8314
2023 Q1	$12.1K	Buy	+2,000	New	+$13.9K	﹤0.01%	5836

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Group One Trading's OMGA Position: Q1 2025 in Review

Group One Trading sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 900 shares — an estimated $671 sold.

Group One Trading first reported a position in OMGA in Q1 2023 and held it in 7 quarters. The position peaked at $18.5K in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Group One Trading reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Group One Trading sold 900 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $671.
Group One Trading first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
Group One Trading's Omega Therapeutics, Inc. Common Stock position peaked at $18.5K in Q1 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.